No photo of R. Ruijter

R. Ruijter

20022019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 9 Article
  • 1 Meeting Abstract
2002

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

Giaccone, G., Punt, C. J. A., Ando, Y., Ruijter, R., Nishi, N., Peters, M., von Blomberg, B. M. E., Scheper, R. J., van der Vliet, H. J. J., van den Eertwegh, A. J. M., Roelvink, M., Beijnen, J., Zwierzina, H. & Pinedo, H. M., Dec 2002, In : Clinical Cancer Research. 8, 12, p. 3702-9 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

2009

A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion

van Riel, J. M. G. H., Peters, G. J., Mammatas, L. H., Honeywell, R. J., Laan, A. C., Ruijter, R., van den Berg, F. G., Giaccone, G. & van Groeningen, C. J., 2009, In : European Journal of Cancer. 45, 14, p. 2519-2527

Research output: Contribution to journalArticleAcademicpeer-review

Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas

Giaccone, G., Rajan, A., Ruijter, R., Smit, E. F., van Groeningen, C. J. & Hogendoorn, P. C. W., 2009, In : Journal of Thoracic Oncology. 4, 10, p. 1270-1273

Research output: Contribution to journalArticleAcademicpeer-review

2010

A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG(1) Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

Kuenen, B. C., Witteveen, P. O., Ruijter, R., Giaccone, G., Dontabhaktuni, A., Fox, F., Katz, T., Youssoufian, H., Zhu, J. M., Rowinsky, E. K. & Voest, E. E., 2010, In : Clinical Cancer Research. 16, 6, p. 1915-1923

Research output: Contribution to journalArticleAcademicpeer-review

2011

Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies

Schoffski, P., Dumez, H., Ruijter, R., Miguel-Lillo, B., Soto-Matos, A., Alfaro, V. & Giaccone, G., 2011, In : Cancer Chemotherapy and Pharmacology. 68, 6, p. 1397-1403

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
61 Downloads (Pure)
2012

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Kaye, S., Aamdal, S., Jones, R., Freyer, G., Pujade-Lauraine, E., de Vries, E. G. E., Barriuso, J., Sandhu, S., Tan, D. S. W., Hartog, V., Kuenen, B., Ruijter, R., Kristensen, G. B., Nyakas, M., Barrett, S., Burke, W., Pietersma, D., Stuart, M., Emeribe, U. & Boven, E., 2012, In : British Journal of Cancer. 106, 11, p. 1728-1734

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File
61 Downloads (Pure)
2017

A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

Rovithi, M., Labots, M., Richard, Honeywell, Ten Tije, A. J., Ruijter, R., Skardhamar, M., Peters, G. J., Voortman, J. & Verheul, H. M. W., 20 May 2017, In : Journal of Clinical Oncology. 35

Research output: Contribution to journalMeeting AbstractAcademic

2018
Open Access